Literature DB >> 32514789

Improvement of the recombinant human coagulation factor IX expression by co-expression of a novel transcript of Drosophila γ carboxylase in a human cell line.

Solmaz Moniri Javadhesari1,2, Alireza Zomorodipour3.   

Abstract

OBJECTIVE: Mammalian cells as the main host for production of human proteins are incapable of complete γ-carboxylation of over-expressed Vitamin K Dependent (VKD) proteins. The Drosophila γ-glutamyl carboxylase (DγC) has been shown to be more efficient than its human counterpart in γ-carboxylation of human substrates, in vitro. Considering the Drosophila γ-carboxylase (DγC) efficiency, in comparison with its human counterpart, for recognition and γ-carboxylation of a human substrate in vitro, we were determined to study the effect of the DγC on the hFIX expression in a mammalian cell line. With this aim, we examined co-expression of the DγC with the hFIX, in a human cell line.
RESULTS: While the co-expression of a complete DγC cDNA reduced the hFIX expression, a truncated form of DγC could improve both the expression level (up to 1211 ng/106 cells/ml on the 4th day of post-transfection) and carboxylation of the expressed hFIX, significantly (p < 0.009).
CONCLUSIONS: Our findings provided evidences for potential of a partial fragment of the DγC for improvement of the γ-carboxylation of a human substrate in a mammalian cell. Our experimental data, in accordance with in silico analysis suggested that the DγC C-terminal fragment, with the advantage of a Kozak-like element has the potential of being expressed as a separate internal translation unit, to generate a peptide with appropriate γ-carboxylase activity.

Entities:  

Keywords:  Drosophila melanogaster; Gamma-carboxylase; Human coagulation factor IX; Vitamin-K dependent (VKD) proteins

Mesh:

Substances:

Year:  2020        PMID: 32514789     DOI: 10.1007/s10529-020-02936-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  7 in total

1.  A hidden Markov model for predicting transmembrane helices in protein sequences.

Authors:  E L Sonnhammer; G von Heijne; A Krogh
Journal:  Proc Int Conf Intell Syst Mol Biol       Date:  1998

2.  Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; B C Furie; B Furie; C B Shoemaker
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

3.  Identification of the vitamin K-dependent carboxylase active site: Cys-99 and Cys-450 are required for both epoxidation and carboxylation.

Authors:  B N Pudota; M Miyagi; K W Hallgren; K A West; J W Crabb; K S Misono; K L Berkner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 4.  Recombinant expression systems in the pharmaceutical industry.

Authors:  F R Schmidt
Journal:  Appl Microbiol Biotechnol       Date:  2004-07-24       Impact factor: 4.813

5.  The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4.

Authors:  P Galeffi; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  The factor IX gamma-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa.

Authors:  Aysar Aktimur; Melanie A Gabriel; David Gailani; John R Toomey
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

7.  Treatment of hemophilia B: focus on recombinant factor IX.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Cinzia Sissa; Carlo Bonfanti
Journal:  Biologics       Date:  2013-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.